Stock listing
KYMR Stock Price, News, Filings & Events — Kymera Therapeutics, Inc.
Selected listing: KYMR · NASDAQ · USD · US
This page tracks Kymera Therapeutics, Inc.'s KYMR:NASDAQ listing on NASDAQ in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following KYMR:NASDAQ. KYMR:NASDAQ is the stock-level entry point for investors researching Kymera Therapeutics, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Kymera Therapeutics, Inc. (Ticker: KYMR) is a public company based in the United States, focused on developing innovative therapies through its proprietary technology. With a market capitalization of approximately $9.1 billion, Kymera is positioned in the biotechnology sector, aiming to address unmet medical needs. The company's advancements in drug development highlight its commitment to improving patient outcomes.
- Ticker
- KYMR:NASDAQ
- Asset type
- Stock
- Market cap
- $9.96B
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- NASDAQ
- Currency
- USD
Kymera Therapeutics, Inc. KYMR:NASDAQ stock context
This page tracks Kymera Therapeutics, Inc.'s KYMR:NASDAQ listing on NASDAQ in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following KYMR:NASDAQ. KYMR:NASDAQ is the stock-level entry point for investors researching Kymera Therapeutics, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Kymera Therapeutics, Inc. (Ticker: KYMR) is a public company based in the United States, focused on developing innovative therapies through its proprietary technology. With a market capitalization of approximately $9.1 billion, Kymera is positioned in the biotechnology sector, aiming to address unmet medical needs. The company's advancements in drug development highlight its commitment to improving patient outcomes.
Latest news from Kymera Therapeutics, Inc.
Kymera Therapeutics Announces Second Quarter 2026 Financial Results and Provides a Business Update
August 5, 2026
Kymera International Appoints Willson Ropp as Chief Executive Officer
July 29, 2026
Kymera Therapeutics to Report Second Quarter 2026 Financial Results on August 5, 2026
July 28, 2026
Kymera Therapeutics Appoints Terence Rooney, MD, as Chief Medical Officer
July 27, 2026
Kymera Therapeutics Appoints Elizabeth Laws, Ph.D., as Senior Vice President, Global Program Team Leader for KT-621, First-in-Class, Oral...
July 7, 2026
Kymera Therapeutics, Inc. earnings calls
Kymera Therapeutics, Inc. (KYMR) Q2 2026 Earnings Call
August 5, 2026 · Replay with transcript and chapters
Kymera Therapeutics, Inc. (KYMR) Q1 2026 Earnings Call
April 30, 2026 · Replay with transcript and chapters
Kymera Therapeutics, Inc. (KYMR) Q4 2025 Earnings Call
February 26, 2026 · Replay with transcript and chapters
Kymera Therapeutics, Inc. (KYMR) Q3 2025 Earnings Call
November 4, 2025 · Replay with transcript and chapters
Kymera Therapeutics, Inc. (KYMR) Q2 2025 Earnings Call
August 11, 2025 · Replay with transcript and chapters
Kymera Therapeutics, Inc. (KYMR) Q1 2025 Earnings Call
May 9, 2025 · Replay with transcript and chapters
Research Kymera Therapeutics, Inc.
Kymera Therapeutics, Inc. investor report
Review AI stock analysis and investor report context for KYMR:NASDAQ.
Kymera Therapeutics, Inc. company profile
View the public company page for Kymera Therapeutics, Inc. on 6ix.
Kymera Therapeutics, Inc. news
Read company news and market updates connected to Kymera Therapeutics, Inc..
Kymera Therapeutics, Inc. investor events
Find investor webinars, events, and replay context for Kymera Therapeutics, Inc..